Most people leave an eye appointment with a question they thought of ten minutes too late — or one they felt embarrassed to ask. Ask it here instead, anonymously. I answer selected questions in general terms and publish them below, so the next person wondering the same thing finds an answer already waiting.
Real questions from patients and visitors, rewritten to remove identifying details and answered in general terms.
No — not the cataract itself. A cataract is your eye’s natural lens becoming cloudy, and once that lens is removed and replaced with an artificial one, it cannot become cloudy again. The implant does not age the way a natural lens does.
What can happen is something that feels very similar. The lens implant sits inside a thin, clear membrane called the capsule, which is left in place during surgery to hold it. In a meaningful proportion of people, that capsule gradually becomes hazy over months to years — this is called posterior capsule opacification. Vision slowly becomes dimmer or more glare-prone, and people often describe it as “the cataract coming back.”
It is treated with a brief laser procedure called a YAG capsulotomy, which opens a small clear window in the hazy capsule. It is done in the office, takes a few minutes, needs no incision, and generally does not need to be repeated.
This is probably the single most important thing to understand about glaucoma, and it is the reason so many people stop their drops without realizing what they are risking.
Glaucoma damages the optic nerve from the periphery inward, and the brain is remarkably good at filling in the missing edges using the other eye and your own eye movements. By the time a person actually notices a gap in their vision, a substantial amount of nerve tissue has usually already been lost — and that loss is permanent. There is no treatment that restores it.
So the drops are not treating a symptom. They are lowering eye pressure, which is the only intervention proven to slow the disease, and the vision they are protecting is the vision you have right now. Feeling fine is the expected state of someone whose glaucoma is being managed well — it is evidence the plan is working, not evidence the plan is unnecessary.
Staging the two eyes, usually by a few weeks, is standard practice in most of the world for a few connected reasons.
The first is safety. Serious complications after cataract surgery are rare, but operating on separate days means an unexpected problem can never affect both eyes at once — you always have a functioning eye while the other heals.
The second is refinement. Choosing the power of a lens implant involves measurement and prediction, and the actual result in the first eye is useful information. If the outcome lands slightly differently than expected, that can be accounted for when planning the second eye.
The third is simply practical: recovery in the first eye tells you and your surgeon how your eyes respond — how much inflammation, how quickly vision settles — before committing the second eye to the same plan.
An occasional missed dose is not a crisis. In general, take it when you remember, and if it is nearly time for the next dose, skip the missed one rather than doubling up — more drops at once does not produce more effect, since the eye can only hold a fraction of a single drop.
The part worth taking seriously is the pattern. Pressure-lowering drops work by being present continuously, so frequent gaps mean the pressure is high for stretches of time that never show up on a single reading in the office. A pressure that looks acceptable at every visit can coexist with a disease that keeps progressing, and missed doses are one of the common explanations.
If you are missing doses often, it is far more useful to say so than to hide it. Difficulty aiming the bottle, stinging, cost, and complicated schedules are all common and all fixable — but only if your provider knows. There are usually alternatives, and a regimen you actually take beats a better one you do not.
A first visit typically includes a thorough history, vision testing, eye pressure measurements, slit-lamp examination, and imaging or visual field testing when indicated. The goal is to understand your eye health fully and discuss a clear, reasoned plan together.
Timing depends on how your cataract is affecting daily activities — reading, driving, glare at night — along with your exam findings and any other eye conditions. We will review potential benefits, risks, and alternatives before making any plan together.
Glaucoma is a long-term condition that can progress silently before affecting central vision — most glaucoma patients are asymptomatic until it is too late. Repeating visual field tests, OCT scans, and pressure checks helps us determine whether the disease is stable or changing — and adjust treatment to minimize deterioration of vision.
Micro-invasive glaucoma surgeries (MIGS) use smaller incisions and typically have a faster recovery and a more favorable safety profile than traditional procedures such as trabeculectomy or tube shunts, but MIGS may not have the lasting effect seen with traditional surgeries. MIGS are often performed alongside cataract surgery, adding only a few minutes to the procedure. The right approach depends on the severity of your glaucoma and individual factors.
Yes. Dr. Bhargava also speaks Hindi and Urdu and welcomes patients from diverse linguistic and cultural backgrounds. Interpretation services are available for all languages.
No answered questions in this topic yet.